Protia Inc. (KOSDAQ: 303360)

Market Cap	37.41B
Revenue	n/a
Net Income	n/a
Shares Out	12.88M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,402
Open	2,680.00
Previous Close	2,680.00
Day's Range	2,680.00 - 2,805.00
52-Week Range	2,575.00 - 3,905.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Protia

Protia Inc. designs, develops, and sells diagnostic kits in South Korea. The company offers PROTIA Allergy-Q, an assay kit for quantitative determination of specific IgE antibodies against individual allergens in human serum using immunoblotting technique; ImmuneCheck IgG, a whole blood test kit for total IgG concentration measurement; and TriCheck-C, an in vitro diagnostic kit for the qualitative test of human chorionic gonadotropin in human urine samples for the pregnancy diagnosis. It also provides protia food iga, a chronic food intolerance...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2000
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 303360